A Phase 3 single-arm multicenter study of FF-31501 in meniscus tear patients
A Phase 3 Single-arm Multicenter Study of FF-31501 in Meniscus Tear Patients
A single-arm, multi-center study to verify that knee joint function at 52 weeks after injection of FF-31501 is better than at screening in patients with meniscus tear who are eligible for meniscectomy .
100 项与 FF-31501 相关的专利(医药)